Status: Recruiting
Access Cannulation Trial II
This is a pivotal, interventional, prospective, single-arm, open-label, multi-site clinical investigation intended to support FDA clearance of the study device based on the safety and efficacy of the device in cannulating arteriovenous fistulas (AVFs) for hemodialysis procedures.
Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Voyager BiomedicalUpdated: Oct 29, 2025Locations: 8
Eligibility criteria
Arterial/Pull Zone: _____ mm deep [+33]